The Effect of Split-belt Treadmill Training on Gait in Parkinson's Disease

Sponsor
KU Leuven (Other)
Overall Status
Completed
CT.gov ID
NCT04176263
Collaborator
University of Kiel (Other)
52
2
2
21
26
1.2

Study Details

Study Description

Brief Summary

People with Parkinson's disease (PD) often show gait impairments such as, shuffling gait, short steps and gait asymmetry and irregularity. These gait problems are already apparent in the early disease stages, having an immense effect on daily life functioning. Especially Freezing of Gait (FOG), where the patients are not able to initiate or continue their movement despite their intention to do so, is a debilitating problem. It is thought that lack of gait adaptability could be an underlying cause of FOG. With a split-belt treadmill the speed of both legs can be controlled independently, which forces participants to actively adapt their gait to the new situation. In a previous study performed at our lab, it was shown that only one session of split-belt training (SBT), in which the speed of one leg was reduced, improved gait adaptability and other gait features compared to tied-belt training (TBT). Furthermore, overground turning speed improved after only one single training session and this was even retained 24 hours later, indicating training induced long-term potentiation. Since the short-term effects of SBT are promising, the objective of this study is to investigate if 4 weeks of SBT, 3 times a week, has an effect on gait deficits found in individuals with PD, compared to 4-weeks, 3 times a week, of TBT.

Condition or Disease Intervention/Treatment Phase
  • Behavioral: SBT
  • Behavioral: TBT
N/A

Study Design

Study Type:
Interventional
Actual Enrollment :
52 participants
Allocation:
Randomized
Intervention Model:
Parallel Assignment
Intervention Model Description:
Overground turning speed during single and dual-task will be compared between a group who will receive 4 weeks of SBT 3 times a week and a group who will receive TBT in the same dose. Participants will be randomized (1:1) to either the SBT or TBT groups by an independent researcher who is not involved in the measurements of any of the studies using a computerized random number generation technique. The randomization will be stratified based on H&Y stage and freezing status (freezer/non-freezer).Overground turning speed during single and dual-task will be compared between a group who will receive 4 weeks of SBT 3 times a week and a group who will receive TBT in the same dose. Participants will be randomized (1:1) to either the SBT or TBT groups by an independent researcher who is not involved in the measurements of any of the studies using a computerized random number generation technique. The randomization will be stratified based on H&Y stage and freezing status (freezer/non-freezer).
Masking:
Double (Participant, Outcomes Assessor)
Masking Description:
The assessors will be single blinded. Participants will be semi-blinded. The participants will be told that they can be assigned to one of the two forms of treadmill training.They do not know the exact content of the training they would receive and what training is given in the other arm.
Primary Purpose:
Treatment
Official Title:
The Impact of Split-belt Treadmill Training to Modulate Freezing-related Gait Deficits and Freezing Episodes in Parkinson's Disease
Actual Study Start Date :
Aug 12, 2019
Actual Primary Completion Date :
May 11, 2021
Actual Study Completion Date :
May 11, 2021

Arms and Interventions

Arm Intervention/Treatment
Experimental: SBT

The SBT group will receive a 4-week split-belt treadmill training program consisting of 3 training sessions every week. The training will have a progression of training duration over the four weeks. Participants will start at a total training duration of 30 minutes and this will be increased with 5 minutes every week. The maximal length will be 45 minutes of training. One session including breaks will take approximately 1 hour.

Behavioral: SBT
The SBT group will receive a 4-week split-belt treadmill training, 3 times a week using a standardized progression protocol. The sessions, including breaks, will approximately take 1 hour each. The training will be given by a trainer experienced with PD.

Active Comparator: TBT

The TBT group will receive a 4-week tied-belt treadmill training program consisting of 3 training sessions every week. The training will have a progression of training duration over the four weeks. Participants will start at a total training duration of 30 minutes and this will be increased with 5 minutes every week. The maximal length will be 45 minutes of training. One session including breaks will take approximately 1 hour.

Behavioral: TBT
The TBT group will receive a 4-week tied-belt treadmill training, 3 times a week. To make sure exposure of the two interventions is similar the sessions of the TBT group will be of similar length and progression level (approximately 1 hour each). The training will be given by a trainer experienced with PD.

Outcome Measures

Primary Outcome Measures

  1. Average overground 360 degree turning speed (degrees/s) [Change in performance between the average overground turning speed from pre to post intervention (i.e. the week after the 4-week training period ended)]

    Participants will be instructed to turn 360 degrees in alternating directions (clockwise/counterclockwise) for 60 seconds. The instruction is to turn as quickly as possible, while still feeling safe doing this. The average overground turning speed will be determined by the use of APDM Opal accelerometers which will be worn on both feet, wrists and the lower back.

Secondary Outcome Measures

  1. Average dual task overground 360 degree turning speed (degrees/sec) [Change in performance between the average overground turning speed from pre to post intervention (i.e. the week after the 4-week training period ended)]

    Participants will be instructed to turn 360 degrees in alternating directions (clockwise/counterclockwise) for 60 seconds. The instruction is to turn as quickly as possible, while still feeling safe doing this. The average overground turning speed will be determined by the use of APDM Opal accelerometers which will be worn on both feet, wrists and the lower back. In addition to this task the participants also have to perform an auditory stroop task. The participant hears the words 'low' and 'high' in either a low or high pitch in random order and timing. The participant has to respond as quickly as possible to the pitch of the word and not to the word itself.

  2. Retention of average overground 360 degree turning speed (degrees/sec) [Change in performance from post-intervention 1 week after the 4-week training period ended (Retest 1) to retention, 5 weeks later (Retest 2).]

    Participants will be instructed to turn 360 degrees in alternating directions (clockwise/counterclockwise) for 60 seconds. The instruction is to turn as quickly as possible, while still feeling safe doing this. The average overground turning speed will be determined by the use of APDM Opal accelerometers which will be worn on both feet, wrists and the lower back.

  3. Retention of dual task average overground 360 degree turning speed (degrees/sec) [Change in performance from post-intervention 1 week after the 4-week training period ended (Retest 1) to retention, 5 weeks later (Retest 2).]

    Participants will be instructed to turn 360 degrees in alternating directions (clockwise/counterclockwise) for 60 seconds. The instruction is to turn as quickly as possible, while still feeling safe doing this. The average overground turning speed will be determined by the use of APDM Opal accelerometers which will be worn on both feet, wrists and the lower back. In addition to this task the participants also have to perform an auditory stroop task. The participant hears the words 'low' and 'high' in either a low or high pitch in random order and timing. The participant has to respond as quickly as possible to the pitch of the word and not to the word itself.

Eligibility Criteria

Criteria

Ages Eligible for Study:
N/A and Older
Sexes Eligible for Study:
All
Accepts Healthy Volunteers:
No
Inclusion Criteria:
  1. Clinical diagnosis of PD according to the recent criteria of the Movement Disorders Society made by a neurologist

  2. Participants should be able to walk 5 minutes at a stretch without a walking aid

  3. Hoehn & Yahr stage II or III in the ON state of medication

  4. Mini Mental State Examination score of 24 or above

  5. Participants should have a steady medication schedule at the start of the study (no change in the past month).

  6. To be included as a freezer participant a score of at least 1 or higher should be recorded with the New Freezing of Gait Questionnaire.

Exclusion Criteria:
  1. Current enrollment in another clinical study which may interfere with the conduction of this study.

  2. Orthopedic injuries or other musculoskeletal problems, which could possibly effect balance and/or gait.

  3. Unable or unwilling to commit to 4 weeks of training, 3 times a week

  4. Participation in walking training in the month prior to the start of the study

  5. Other neurological impairments (except PD)

  6. Cardiovascular exercise risk factors diagnosed by a doctor

Contacts and Locations

Locations

Site City State Country Postal Code
1 KU Leuven Leuven Vlaams-Brabant Belgium 3001
2 University Hospital Schleswig-Holstein (UKSH), Christian-Albrechts-University Kiel Kiel Schleswig-Holstein Germany 24105

Sponsors and Collaborators

  • KU Leuven
  • University of Kiel

Investigators

  • Principal Investigator: Alice Nieuwboer, PhD, KU Leuven
  • Principal Investigator: Christian Schlenstedt, PhD, Christian Albrechts University of Kiel

Study Documents (Full-Text)

More Information

Publications

Responsible Party:
Alice Nieuwboer, Professor, KU Leuven
ClinicalTrials.gov Identifier:
NCT04176263
Other Study ID Numbers:
  • S62825 (KUL); D454/13 (CAU)
  • None was given
First Posted:
Nov 25, 2019
Last Update Posted:
Aug 10, 2021
Last Verified:
Aug 1, 2021
Studies a U.S. FDA-regulated Drug Product:
No
Studies a U.S. FDA-regulated Device Product:
No
Keywords provided by Alice Nieuwboer, Professor, KU Leuven
Additional relevant MeSH terms:

Study Results

No Results Posted as of Aug 10, 2021